Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 1.362
Filter
1.
Thorac Cancer ; 13(16): 2390-2393, 2022 08.
Article in English | MEDLINE | ID: mdl-35793785

ABSTRACT

Radiation therapy can cause radiation pneumonitis, organizing pneumonia, and lung fibrosis. Radiation-induced pseudomembranous bronchitis is a rare condition. Here, we describe a rare case each of pseudomembranous tracheobronchitis and pseudomembrane with total bronchial obstruction which developed after thoracic radiotherapy. A 50-year-old man presented paroxysmal severe cough 1 month after concurrent chemoradiotherapy for small-cell lung cancer. Bronchoscopy revealed a whitish membrane in the trachea and bronchus, which were the fields of radiation. Another 60-year-old man complained of dyspnea 7 months after radiation therapy for metastatic lymph node adenocarcinoma. Bronchoscopy demonstrated a membrane with total obstruction of right lower lobar bronchus, which was the area of radiation. The pathological findings of histological examination in both cases demonstrated radiation-induced pseudomembranous tracheobronchitis. Patients in both cases responded well to steroids and the pseudomembrane disappeared. If patients who have received thoracic radiation therapy complain of persistent cough, bronchoscopy may be helpful.


Subject(s)
Adenocarcinoma , Bronchitis , Radiation Pneumonitis , Tracheitis , Adenocarcinoma/complications , Bronchitis/complications , Bronchitis/pathology , Bronchoscopy/adverse effects , Cough , Humans , Male , Middle Aged , Tracheitis/etiology , Tracheitis/pathology
4.
Contrast Media Mol Imaging ; 2021: 2748830, 2021.
Article in English | MEDLINE | ID: mdl-34621144

ABSTRACT

Objective: The study focused on the features of the convolutional neural networks- (CNN-) processed magnetic resonance imaging (MRI) images for plastic bronchitis (PB) in children. Methods: 30 PB children were selected as subjects, including 19 boys and 11 girls. They all received the MRI examination for the chest. Then, a CNN-based algorithm was constructed and compared with Active Appearance Model (AAM) algorithm for segmentation effects of MRI images in 30 PB children, factoring into occurring simultaneously than (OST), Dice, and Jaccard coefficient. Results: The maximum Dice coefficient of CNN algorithm reached 0.946, while that of active AAM was 0.843, and the Jaccard coefficient of CNN algorithm was also higher (0.894 vs. 0.758, P < 0.05). The MRI images showed pulmonary inflammation in all subjects. Of 30 patients, 14 (46.66%) had complicated pulmonary atelectasis, 9 (30%) had the complicated pleural effusion, 3 (10%) had pneumothorax, 2 (6.67%) had complicated mediastinal emphysema, and 2 (6.67%) had complicated pneumopericardium. Also, of 30 patients, 19 (63.33%) had lung consolidation and atelectasis in a single lung lobe and 11 (36.67%) in both two lung lobes. Conclusion: The algorithm based on CNN can significantly improve the segmentation accuracy of MRI images for plastic bronchitis in children. The pleural effusion was a dangerous factor for the occurrence and development of PB.


Subject(s)
Bronchitis/diagnosis , Image Processing, Computer-Assisted , Lung/diagnostic imaging , Magnetic Resonance Imaging , Algorithms , Bronchitis/diagnostic imaging , Bronchitis/pathology , Child , Female , Humans , Lung/pathology , Male , Neural Networks, Computer
6.
Front Immunol ; 12: 594330, 2021.
Article in English | MEDLINE | ID: mdl-33828547

ABSTRACT

Cigarette smoke (CS)-induced macrophage activation and airway epithelial injury are both critical for the development of chronic obstructive pulmonary disease (COPD), while the eventual functions of autophagy in these processes remain controversial. We have recently developed a novel COPD mouse model which is based on the autoimmune response sensitized by CS and facilitated by elastin. In the current study, we therefore utilized this model to investigate the roles of autophagy in different stages of the development of bronchitis-like airway inflammation. Autophagic markers were increased in airway epithelium and lung tissues, and Becn+/- or Lc3b-/- mice exhibited reduced neutrophilic airway inflammation and mucus hyperproduction in this COPD mouse model. Moreover, treatment of an autophagic inhibitor 3-methyladenine (3-MA) either during CS-initiated sensitization or during elastin provocation significantly inhibited the bronchitis-like phenotypes in mice. Short CS exposure rapidly induced expression of matrix metallopeptidase 12 (MMP12) in alveolar macrophages, and treatment of doxycycline, a pan metalloproteinase inhibitor, during CS exposure effectively attenuated the ensuing elastin-induced airway inflammation in mice. CS extract triggered MMP12 expression in cultured macrophages, which was attenuated by autophagy impairment (Becn+/- or Lc3b-/-) or inhibition (3-MA or Spautin-1). These data, taken together, demonstrate that autophagy mediates both the CS-initiated MMP12 activation in macrophages and subsequent airway epithelial injury, eventually contributing to development COPD-like airway inflammation. This study reemphasizes that inhibition of autophagy as a novel therapeutic strategy for CS-induced COPD.


Subject(s)
Autophagy , Bronchitis/etiology , Bronchitis/metabolism , Elastin/metabolism , Tobacco Smoke Pollution/adverse effects , Animals , Biomarkers , Bronchitis/pathology , Cell Line , Cells, Cultured , Disease Models, Animal , Disease Susceptibility , Elastin/genetics , Gene Expression , Humans , Immunohistochemistry , Lung/metabolism , Lung/pathology , Macrophages, Alveolar/immunology , Macrophages, Alveolar/metabolism , Macrophages, Alveolar/pathology , Male , Matrix Metalloproteinase 12/genetics , Matrix Metalloproteinase 12/metabolism , Mice
9.
Pediatr Pulmonol ; 55(4): 909-917, 2020 04.
Article in English | MEDLINE | ID: mdl-32040879

ABSTRACT

OBJECTIVES: Pediatric lymphocytic interstitial pneumonia (LIP) and follicular bronchiolitis (FB) are poorly characterized lymphoproliferative disorders. We present and quantify demographics, radiological and histopathologic patterns, treatments and their responses, and outcomes in non-HIV-infected children with LIP and FB. METHODS: This structured registry-based study included a retrospective chart review, blinded analysis of imaging studies and lung biopsies, genetic testing, and evaluation of treatments and outcomes. RESULTS: Of the 13 patients (eight females) studied, eight had FB, four had combined LIP/FB, and one had isolated LIP; diagnoses were highly concordant between the pathologists. Most patients became symptomatic during the first 2 years of life, with a mean lag time to diagnosis of 4 years. The most common symptoms were coughing and respiratory infections (11 out of 13 each), dyspnea (10 out of 13), and wheezing (eight out of 13). Autoantibodies were found in eight out of 13 patients. In three patients, disease-causing mutations in the COPA gene were identified. CT revealed hilar lymphadenopathy (five out of 12), ground-glass opacity (eight out of 12), consolidation (five out of 12), and cysts (four out of 13). Systemic steroids as intravenous pulses (11 out of 13) or oral intake (10 out of 13) were the main treatments and showed high response rates of 100% and 90%, respectively. Within the mean observation period of 68 months, all children had chronic courses, eight out of 13 had severe diseases, two died, and one worsened. CONCLUSIONS: Children with LIP/FB have chronic diseases that occurred in early childhood and were commonly associated with immune dysregulation as well as high morbidity and mortality. Early diagnosis and treatment may be crucial to improve the outcome.


Subject(s)
Bronchitis/complications , Lung Diseases, Interstitial/complications , Adolescent , Age of Onset , Biopsy , Bronchitis/diagnosis , Bronchitis/drug therapy , Bronchitis/pathology , Child , Child, Preschool , Chronic Disease , Cough/etiology , Diagnosis, Differential , Dyspnea/etiology , Female , Genetic Testing , Humans , Infant , Lung/diagnostic imaging , Lung/pathology , Lung Diseases/diagnosis , Lung Diseases, Interstitial/diagnosis , Lung Diseases, Interstitial/drug therapy , Lung Diseases, Interstitial/pathology , Male , Registries , Respiratory Sounds/etiology , Respiratory Tract Infections/etiology , Retrospective Studies , Tomography, X-Ray Computed
10.
Article in English | MEDLINE | ID: mdl-31926085

ABSTRACT

Background Inappropriate antibiotic therapy is accelerating the development of antimicrobial resistance (AMR). Upper respiratory tract infections (URTIs) are predominantly caused by viruses, resulting in the prescription of antibiotics to a few selected patients. Previous studies in primary health care centers (PHCCs) in Indonesia have shown a high percentage of antibiotic therapy for URTIs. This study tries to analyze the difference in profiles of antibiotic prescription in the treatment of children and adults with URTI in Bangka Tengah, Indonesia. Methods Random prescriptions from patients diagnosed with URTIs (sinusitis, bronchitis, common cold, and pharyngitis) from all PHCCs in Bangka Tengah were collected from January to February 2018. Prescriptions from patients with overlapping diagnoses, such as URTI with diarrhea or typhoid, were excluded. Results During the two months of data collection, 1348 prescriptions for adults and children with URTIs were studied. Children were 1.30 (95% CI, 1.03-1.58) times more likely to be treated with antibiotics compared to adults. Amoxicillin was the most commonly prescribed antibiotic both in children (92.3%) and adults (78.6%). Ciprofloxacin was commonly prescribed in adults (14.6%) but not in children (0.3%). Conclusions This study confirms the major antibiotic overuse in patients with URTI, especially in children. Owing to the fact that children are more likely to get URTI of viral origin, they receive high percentage of antibiotic therapy. These findings support the need for collaborated intervention to decrease unnecessary prescription of antibiotics in Bangka Tengah.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Bronchitis/drug therapy , Drug Utilization/statistics & numerical data , Pharyngitis/drug therapy , Prescription Drug Overuse/statistics & numerical data , Respiratory Tract Infections/drug therapy , Sinusitis/drug therapy , Adolescent , Adult , Bronchitis/microbiology , Bronchitis/pathology , Child , Child, Preschool , Female , Humans , Indonesia , Infant , Infant, Newborn , Male , Middle Aged , Pharyngitis/microbiology , Pharyngitis/pathology , Practice Patterns, Physicians'/standards , Primary Health Care , Respiratory Tract Infections/microbiology , Respiratory Tract Infections/pathology , Sinusitis/microbiology , Sinusitis/pathology , Unnecessary Procedures , Young Adult
11.
Medicine (Baltimore) ; 99(1): e18647, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31895828

ABSTRACT

RATIONALE: Influenza is an infection caused by the influenza virus, and its symptoms are mostly mild and self-limiting. However, influenza can cause severe or fatal complications in high-risk patients. Although tracheobronchitis is one of the common complications of influenza, necrotizing tracheobronchitis is very rare. Herein, we describe a case of necrotizing tracheobronchitis causing airway obstruction complicated by pandemic 2009 H1N1 influenza. PATIENT CONCERNS: A 60-year-old man presented with fever and dyspnea. On arrival at the emergency room (ER), the patient received oxygen 4 L/minute via a nasal prolong owing to mild hypoxemia. And invasive mechanical ventilation was needed 5 hours after arrival at the ER due to progressive hypoxemia. DIAGNOSES: Fiberoptic bronchoscopy was performed owing to bloody secretion in the endotracheal tube and revealed diffuse tracheobronchitis with necrotic and hemorrhagic materials obstructing the trachea and bronchus. The pandemic 2009 H1N1 influenza virus was detected from the bronchial washing sample; no other microorganism was detected. INTERVENTION: He received peramivir plus oseltamivir and broad-spectrum antibiotics. OUTCOMES: The bloody secretion continued. He developed cardiac arrest due to airway obstruction on the 6th day of admission. After cardiac arrest, his condition progressed to multi-organ failure, and the patient died on the 10th day of admission. LESSONS: We suggest that necrotizing tracheobronchitis be considered in patients with influenza who present with unexplained hypoxemia.


Subject(s)
Airway Obstruction/virology , Bronchitis/virology , Influenza A Virus, H1N1 Subtype , Influenza, Human/complications , Tracheal Diseases/virology , Bronchi/diagnostic imaging , Bronchi/pathology , Bronchitis/complications , Bronchitis/diagnostic imaging , Bronchitis/pathology , Humans , Male , Middle Aged , Necrosis , Tracheal Diseases/complications , Tracheal Diseases/diagnostic imaging , Tracheal Diseases/pathology
12.
Respir Res ; 20(1): 274, 2019 Dec 04.
Article in English | MEDLINE | ID: mdl-31801520

ABSTRACT

By airway surface liquid, we mean a thin fluid continuum consisting of the airway lining layer and the alveolar lining layer, which not only serves as a protective barrier against foreign particles but also contributes to maintaining normal respiratory mechanics. In recent years, measurements of the rheological properties of airway surface liquid have attracted considerable clinical attention due to new advances in microrheology instruments and methods. This article reviews the clinical relevance of measurements of airway surface liquid viscoelasticity and surface tension from four main aspects: maintaining the stability of the airways and alveoli, preventing ventilator-induced lung injury, optimizing surfactant replacement therapy for respiratory syndrome distress, and characterizing the barrier properties of airway mucus to improve drug and gene delivery. Primary measuring techniques and methods suitable for determining the viscoelasticity and surface tension of airway surface liquid are then introduced with respect to principles, advantages and limitations. Cone and plate viscometers and particle tracking microrheometers are the most commonly used instruments for measuring the bulk viscosity and microviscosity of airway surface liquid, respectively, and pendant drop methods are particularly suitable for the measurement of airway surface liquid surface tension in vitro. Currently, in vivo and in situ measurements of the viscoelasticity and surface tension of the airway surface liquid in humans still presents many challenges.


Subject(s)
Bronchitis/pathology , Pulmonary Disease, Chronic Obstructive/pathology , Pulmonary Surfactants/administration & dosage , Ventilator-Induced Lung Injury/pathology , Animals , Bronchitis/drug therapy , Chronic Disease , Humans , Pulmonary Alveoli/drug effects , Pulmonary Alveoli/pathology , Pulmonary Disease, Chronic Obstructive/drug therapy , Respiratory Mechanics , Rheology , Sensitivity and Specificity , Surface Tension/drug effects , Ventilator-Induced Lung Injury/drug therapy , Viscosity
14.
Biomed Pharmacother ; 118: 109315, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31545256

ABSTRACT

Qingyan formulation (QF) is a common preparation that is often used to control inflammation in the haze environment. However, the efficacy and effective constituents of QF are still uncertain and difficult to identify. This paper aims to evaluate the efficacy by simulating a haze environment and determine its anti-inflammatory compounds by UPLC/Q-TOF-MS/MS combing with bioactivity screening. The therapeutic effect of QF in the simulated haze environment was confirmed from the aspects of lung histomorphology and inflammatory factor expression levels. QF showed strong anti-inflammatory activity with the minimum effective concentration reaching 1.5 g/kg. Potential anti-inflammatory components were screened by the NF-κB activity assay system and simultaneously identified based on mass spectral data. Then, the potential active compounds were verified by molecular biological methods, the minimum effective concentration can reach 0.1 mg/L. Six structural types of NF-κB inhibitors (phenolic acid, scopolamine, hydroxycinnamic acid, flavonoid, dihydroflavone and steroid) were identified. Further cytokine assays confirmed their potential anti-inflammatory effects of NF-κB inhibitors. This strategy clearly demonstrates that QF has a significant therapeutic effect on respiratory diseases caused by haze, so it is necessary to promote its commercialization and wider application.


Subject(s)
Anti-Inflammatory Agents/analysis , Anti-Inflammatory Agents/pharmacology , Drugs, Chinese Herbal/pharmacology , Smoke , Animals , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/therapeutic use , Bronchi/drug effects , Bronchi/pathology , Bronchi/physiopathology , Bronchitis/drug therapy , Bronchitis/pathology , Chronic Disease , Disease Models, Animal , Drugs, Chinese Herbal/chemistry , Drugs, Chinese Herbal/therapeutic use , HEK293 Cells , Humans , Inflammation Mediators/metabolism , Lung/pathology , Lung/physiopathology , Lung Injury/blood , Lung Injury/drug therapy , Lung Injury/pathology , Mice , NF-kappa B/metabolism , Pulmonary Alveoli/drug effects , Pulmonary Alveoli/pathology , Pulmonary Alveoli/physiopathology
15.
Thorax ; 74(8): 768-779, 2019 08.
Article in English | MEDLINE | ID: mdl-31142617

ABSTRACT

BACKGROUND: Air pollution, including particulates and gazes such as ozone (O3), is detrimental for patient's health and has repeatedly been correlated to increased morbidity and mortality in industrialised countries. Although studies have described a link between ambient particulate matter and increased lung cancer morbidity, no direct relation has yet been established between O3 exposure and metastatic dissemination to lungs. OBJECTIVES: To outline the mechanisms through which pulmonary O3 exposure modulates metastasis kinetics in an experimental mouse model of O3 exposure. METHODS: Metastatic responses to pulmonary O3 exposure were assessed using a reliable experimental mouse model of concomitant pulmonary O3 exposure and tumour cell injection. Roles of neutrophils in O3-induced lung metastasis were highlighted using blocking anti-Ly6G antibodies; moreover, the implication of neutrophil extracellular traps (NETs) in metastatic processes was evaluated using MRP8cre-Pad4lox/lox mice or by treating mice with DNase I. RESULTS: Pulmonary O3 exposure strongly facilitates the establishment of lung metastasis by (1) Inducing a pulmonary injury and neutrophilic inflammation, (2) Influencing very early steps of metastasis, (3) Priming neutrophils' phenotype to release NETs that favour tumour cell colonisation in lungs. The ability of O3-primed neutrophils to enhance lung colonisation by tumour cells was proven after their adoptive transfer in Balb/c mice unexposed to O3. CONCLUSIONS: Pulmonary neutrophils induced by O3 promote metastatic dissemination to lungs by producing NETs. These findings open new perspectives to improve treatment and prevention strategies in patients affected by metastatic diseases.


Subject(s)
Breast Neoplasms/pathology , Extracellular Traps , Lung Neoplasms/secondary , Melanoma/pathology , Neoplasm Metastasis , Neutrophils/pathology , Ozone/toxicity , Animals , Antibodies/pharmacology , Antigens, Ly/immunology , Bronchitis/chemically induced , Bronchitis/pathology , Bronchoalveolar Lavage Fluid/cytology , Cell Line, Tumor , Deoxyribonuclease I/pharmacology , Disease Models, Animal , Leukocyte Count , Lung Injury/chemically induced , Lung Injury/pathology , Lung Neoplasms/pathology , Mice , Mice, Inbred BALB C , Neoplasm Metastasis/genetics , Neoplasm Transplantation , Neutrophils/drug effects , Pneumonia/chemically induced , Pneumonia/pathology , Protein-Arginine Deiminase Type 4/genetics
16.
Respiration ; 98(2): 157-164, 2019.
Article in English | MEDLINE | ID: mdl-31067555

ABSTRACT

BACKGROUND: Tracheobronchial fungal infections (TBFI) cause life-threatening complications in immunocompromised hosts but are rarely reported. Misdiagnosis and delayed antifungal treatment are associated with the high mortality rate of patients with TBFI. OBJECTIVES: This study analyzed the bronchoscopic features of TBFI and their roles in the early diagnosis of TBFI. METHODS: The demographic, clinical, radiologic, and bronchoscopic data of 53 patients diagnosed with TBFI in our department during a 15-year period were retrospectively analyzed. RESULTS: Most of the TBFI patients were male, and mass was the most common radiologic abnormality. Obvious predilection in primary bronchus distributions was observed. 41.9% of the 43 Aspergillus tracheobronchitis (AT) patients, 70% of the 10 tracheobronchial mucormycosis (TM) patients, and 100% of the 3 endobronchial cryptococcosis patients had been misdiagnosed as having cancer on bronchoscopy because of the presence of tumor-like lesions. The most common features of AT were bronchial occlusion with a mass or mucosal necrosis, bronchial stenosis with mucosal hyperplasia, or uneven mucosa. The main descriptions of TM were bronchial stenosis or obstruction due to mucosal necrosis, uneven mucosa, or a mass. The endoscopic characteristics of endobronchial cryptococcosis included occlusion due to uneven mucosa or mass, or external compressive stricture. CONCLUSION: Immunocompromised patients and immunocompetent patients with underlying disease displaying tumor-like lesions on bronchoscopy should be differentially diagnosed with cancer. Bronchial biopsy is indispensable for the early diagnosis of TBFI.


Subject(s)
Bronchial Neoplasms/diagnosis , Bronchitis/diagnosis , Bronchoscopy , Cryptococcosis/diagnosis , Mucormycosis/diagnosis , Pulmonary Aspergillosis/diagnosis , Tracheitis/diagnosis , Adult , Aged , Bronchitis/immunology , Bronchitis/pathology , Constriction, Pathologic , Cryptococcosis/immunology , Cryptococcosis/pathology , Diagnosis, Differential , Female , Humans , Hyperplasia , Immunocompetence , Immunocompromised Host , Male , Middle Aged , Mucormycosis/immunology , Mucormycosis/pathology , Pulmonary Aspergillosis/immunology , Pulmonary Aspergillosis/pathology , Respiratory Mucosa/pathology , Retrospective Studies , Tracheitis/immunology , Tracheitis/pathology
18.
Biomed Res Int ; 2019: 7945091, 2019.
Article in English | MEDLINE | ID: mdl-30834276

ABSTRACT

PURPOSE: This study investigated an inhalation solution containing ectoine, a bacterial-derived extremolyte, for the treatment of acute bronchitis and acute respiratory infections in comparison with saline inhalation solution. METHODS: This prospective, controlled, observational study comprised an inclusion visit (day 1), a final visit (day 7), and a follow-up questionnaire (day 17). The treatment itself was administered from day 1 to day 7. The Bronchitis Severity Score, patients' general health, general effectiveness of the treatment, tolerability, and adverse events were compared between two groups. RESULTS: In total, 135 patients were recruited; 79 patients received ectoine inhalation solution and 56 saline inhalation solution. After treatment, symptom scores decreased significantly in both groups (P < 0.05); the reduction in symptom scores was slightly greater in the ectoine group than in the saline group. The first significant reduction in symptom scores (P < 0.05) occurred earlier in the ectoine group than in the saline group. The differences in the area under the curve for the symptoms of dyspnea and auscultation findings were significant in favor of ectoine (P < 0.05). After treatment, more patients and physicians in the ectoine group assessed their or their patients' condition as "completely recovered" or "greatly improved" than those in the saline group. Almost all patients and physicians assessed the tolerability of both treatments as "good" or "very good". CONCLUSIONS: Ectoine inhalation solution seems to be slightly more effective than saline inhalation solution for the treatment of acute bronchitis and acute respiratory infections.


Subject(s)
Acute Disease/therapy , Amino Acids, Diamino/administration & dosage , Bronchitis/drug therapy , Respiratory Tract Infections/drug therapy , Administration, Inhalation , Adolescent , Adult , Aged , Aged, 80 and over , Bronchitis/pathology , Child , Child, Preschool , Female , Humans , Male , Middle Aged , Respiratory Tract Infections/pathology , Saline Solution/administration & dosage , Young Adult
19.
Clin Transplant ; 33(5): e13515, 2019 05.
Article in English | MEDLINE | ID: mdl-30849195

ABSTRACT

Lymphocytic bronchitis (LB) precedes chronic lung allograft dysfunction. The relationships of LB (classified here as Endobronchial or E-grade rejection) to small airway (A- and B-grade) pathologies are unclear. We hypothesized that gene signatures common to allograft rejection would be present in LB. We studied LB in two partially overlapping lung transplant recipient cohorts: Cohort 1 included large airway brushes (6 LB cases and 18 post-transplant referents). Differential expression using DESeq2 was used for pathway analysis and to define an LB-associated metagene. In Cohort 2, eight biopsies for each pathology subtype were matched with pathology-free biopsies from the same subject (totaling 48 samples from 24 subjects). These biopsies were analyzed by multiplexed digital counting of immune transcripts. Metagene score differences were compared by paired t tests. Compared to referents in Cohort 1, LB demonstrated upregulation of allograft rejection pathways, and upregulated genes in these cases characterized an LB-associated metagene. We observed statistically increased expression in Cohort 2 for this LB-associated metagene and four other established allograft rejection metagenes in rejection vs paired non-rejection biopsies for both E-grade and A-grade subtypes, but not B-grade pathology. Gene expression-based categorization of allograft rejection may prove useful in monitoring lung allograft health.


Subject(s)
Biomarkers/analysis , Bronchitis/diagnosis , Gene Expression Profiling , Graft Rejection/diagnosis , Lung Transplantation/adverse effects , Lymphocytes/pathology , Adult , Allografts , Bronchitis/etiology , Bronchitis/pathology , Female , Follow-Up Studies , Graft Rejection/etiology , Graft Rejection/pathology , Graft Survival , Humans , Lymphocytes/metabolism , Male , Middle Aged , Prognosis , Prospective Studies
20.
J Toxicol Sci ; 44(2): 107-112, 2019.
Article in English | MEDLINE | ID: mdl-30726810

ABSTRACT

Inhalation of toxic gases is dangerous to humans; experiments using toxic gases themselves are also hazardous to researchers. Gas-releasing molecules are widely used as alternatives to toxic gases, but their impacts on the whole body remain to be examined. To investigate responses during hydrogen sulfide (H2S) poisoning, rats (Sprague-Dawley, male, 8-week-old) were intraperitoneally (i.p.) administered H2S donor, NaHS, and sacrificed 24 hr after the administration. The main histopathological finding commonly observed in NaHS-administered rat heart, liver, brain, and lung was congestion. In addition, inflammation and accumulation of mucopolysaccharides were observed in bronchioles of the lung. Immunoblot analysis indicated increasing trend of NF-κB activation, and real-time PCR analysis showed increasing tendency of TNFα and IL-1ß, as well as MUC1 and 5B, in NaHS-administered rat lung. Immunohistochemistry by use of anti-MUC1 and 5B antibodies confirmed enhanced mucosal secretion from bronchial epithelium. Moreover, administration of TNFα or IL-1ß to A549 lung epithelial cells resulted with enhanced expressions of MUC1 and 5B. This report shows bronchitis and respiratory mucosal secretion in animal model of H2S intoxication, which is created by i.p. administration of a H2S donor, through NF-κB-TNFα/IL-1ß-ΜUC1/5B pathway.


Subject(s)
Bronchitis/chemically induced , Sulfides/toxicity , A549 Cells , Animals , Brain/drug effects , Brain/pathology , Bronchitis/metabolism , Bronchitis/pathology , Humans , Interleukin-1beta/genetics , Interleukin-1beta/metabolism , Liver/drug effects , Liver/pathology , Lung/drug effects , Lung/metabolism , Lung/pathology , Male , Mucin-1/genetics , Mucin-1/metabolism , Mucin-5B/genetics , Mucin-5B/metabolism , Myocardium/pathology , Rats, Sprague-Dawley , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...